La gestione dell'iperparatiroidismo secondario nella malattia renale cronica allo stadio 3 e 4

Autor: M. Cozzolino, L. Olivi, S. Pasho, G. Fallabrino, E. Volpi, P. Ciceri

Publikováno v: Giornale di Clinica Nefrologia e Dialisi, Vol 21, Iss 1 (2018)

Abstract non disponibile

Externí odkaz: https://doaj.org/article/e7fe28ca894c48f0b5d166367c21d436

Trattamento dell'iperparatiroidismo secondario: calciomimetici, attivatori selettivi del recettore della vitamina D (VDRAs) o terapia combinata?

Autor: M. Cozzolino, S. Pasho, C. Crovetto, E. Missaglia

Publikováno v: Giornale di Clinica Nefrologia e Dialisi, Vol 19, Iss 3-4 (2007)

Abstract non disponibile

Externí odkaz: https://doaj.org/article/2dfb13d6e018473eb9975c500bc703da

ACID BASE, ION DISORDERS, LITHISASIS

Autor: M. A. El-Shahawy, H. S. Rasmussen, P. T. Lavin, A. Yang, D. K. Packham, B. Singh, S. D. Roger, M. Fusaro, L. Dalle Carbonare, A. Dusso, M. V. Arcidiacono, S. Pasho, M. Gallieni, M. S. Ormanji, F. Korkes, R. Meca, L. C. Baia, R. R. Ferraz, I. P. Heilberg, I. Nistor, I. Bararu, M.-C. Apavaloaie, L. Voroneanu, M.-D. Donciu, E. V. Nagler, A. Covic, H.-W. Gil, S.-H. Park, S.-Y. Hong, B. Ponte, H. Alwan, M. Pruijm, D. Ackermann, I. Guessous, G. Ehret, F. Paccaud, M. Mohaupt, A. Pechere-Bertschi, M. Burnier, P.-Y. Martin, M. Bochud, V. Filiopoulos, D. Biblaki, N. Manolios, I. Karatzas, D. Arvanitis, D. Vlassopoulos, A. Altuntas, V. Kidir, S. Inal, S. Diker, N. Cil, H. Orhan, M. T. Sezer, M. Verdelho, N. Rodrigues, F. Ribeiro, W. Y. Qunibi, H. Azar, R. Ossman, M. Flamant, D. Chelala, P. Ria, A. Fabris, C. Branco, G. Gambaro, A. Lupo, J. Hao, L. Qiu, Y. Li, R. Li, X. Li, L. Chen, S. Verdesca, D. Cucchiari, M. Podesta, S. Badalamenti, N. M. H. Veldhuijzen, K. G. F. Gerritsen, W. H. Boer, A. C. Abrahams, F. Mangione, P. Albrizio, V. Sepe, P. Esposito, A. Manini, S. Muciaccia, A. Dal Canton

Publikováno v: Nephrology Dialysis Transplantation. 29:iii178-iii185

Introduction and Aims: Hyperkalaemia is a risk factor for mortality in patients with cardiovascular disease and chronic kidney disease (CKD) (Goyal, 2012; Torlen, 2012) and limits use of renin-angiotensin-aldosterone system inhibitors (RAASi) in thes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::86225bf56856a38dfc250bb1583b2445
https://doi.org/10.1093/ndt/gfu150

Il trattamento dell'iperparatiroidismo secondario con gli analoghi della vitamina D

Autor: Maurizio Gallieni, C. Crovetto, E. Missaglia, S. Pasho

Publikováno v: Giornale di Clinica Nefrologia e Dialisi, Vol 19, Iss 3-4 (2007)

non disponibile

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53c417491e9ada99f1c43daf5484e796
https://doi.org/10.1177/039493620701903-405

[Pathogenesis and treatment of vascular calcification in CKD]

Autor: D, Brancaccio, M, Gallieni, S, Pasho, G, Fallabrino, L, Olivi, E, Volpi, P, Ciceri, E, Missaglia, C, Ronga, C, Brambilla, A, Butti, L, Rocca-Rey, G, Chiarelli, M, Cozzolino

Publikováno v: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia. 26

Increased vascular calcification is a major cause of cardiovascular events in patients with chronic kidney disease (CKD). It is the result of an active ossification process counteracted by ''bone'' proteins such as osteopontin, alkaline phosphatase,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e76ab90999e0cf68d907f5fcd61ef21b
https://pubmed.ncbi.nlm.nih.gov/19382090